Overexpression of miR-214-3p in esophageal squamous cancer cells enhances sensitivity to cisplatin by targeting survivin directly and indirectly through CUG-BP1

Oncogene

Volumn 35, Issue 16, 2016, Pages 2087-2097

  Phatak, P ^a,b   Byrnes, K A ^a,b   Mansour, D ^a,b   Liu, L ^a,b   Cao, S ^a,b   Li, R ^a,b   Rao, J N ^a,b   Turner, D J ^a,b   Wang, J Y ^a,b   Donahue, J M ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b BALTIMORE VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTIN; CASPASE 3; CISPLATIN; CUG BP1 PROTEIN; DACTINOMYCIN; MICRORNA 214; MICRORNA 214 3P; RNA BINDING PROTEIN; SURVIVIN; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; BIRC5 PROTEIN, HUMAN; CELF1 PROTEIN; CELF1 PROTEIN, HUMAN; INHIBITOR OF APOPTOSIS PROTEIN; MICRORNA; MIRN214 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; BINDING SITE; BIOINFORMATICS; CELL LYSATE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; EPITHELIUM CELL; ESOPHAGEAL CANCER CELL LINE; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FLOW CYTOMETRY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA STABILITY; SITE DIRECTED MUTAGENESIS; WILD TYPE; ESOPHAGUS TUMOR; GENETICS; PATHOLOGY; PHYSIOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CELF1 PROTEIN; CELL LINE, TUMOR; CISPLATIN; ESOPHAGEAL NEOPLASMS; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MICRORNAS;

EID: 84938629411     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2015.271     Document Type: Article

References (33)

1. Kaufmann SH, Vaux DL. Alterations in the apoptotic machinery and their potential role in anticancer drug resistance. Oncogene 2003; 22: 7414-7430.
2. Mita AC, Mita MM, Nawrocki ST, Giles FJ. Survivin key regulator of mitosis and apoptosis and novel target for cancer therapeutics. Clin Cancer Res 2008; 14: 5000-5005.
3. Kato J, Kuwabara Y, Mitani M, Shinoda N, Sato A, Toyama T et al. Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy. Int J Cancer 2001; 95: 92-95.
4. Chang E, Donahue J, Smith A, Hornick J, Rao JN, Wang JY et al. Loss of p53, rather than beta-catenin overexpression, induces survivin-mediated resistance to apoptosis in an esophageal cancer cell line. Thorac Cardiovasc Surg 2010; 140: 225-232.
5. Vallböhmer D, Kuhn E, Warnecke-Eberz U, Brabender J, Hoffmann AC, Metzger R et al. Failure in downregulation of intratumoral survivin expression following neoadjuvant chemoradiation in esophageal cancer. Pharmacogenomics 2008; 9: 681-690.
6. Audic Y, Hartley RS. Post-transcriptional regulation in cancer. Biol Cell 2004; 96: 479-498.
7. Di Leva G, Garofalo M, Croce CM. MicroRNAs in cancer. Annu Rev Pathol 2014; 9: 287-314.
8. Cheetham SW, Gruhl F, Mattick JS, Dinger ME. Long noncoding RNAs and the genetics of cancer. Br J Cancer 2013; 108: 2419-2425.
9. Keene JD. RNA regulons: coordination of post-transcriptional events. Nat Rev Genet 2007; 8: 533-543.
10. Chang ET, Donahue JM, Xiao L, Cui Y, Rao JN, Turner DJ et al. The RNA-binding protein CUG-BP1increases survivin expression in oesophageal cancer cells through enhanced mRNA stability. Biochem J 2012; 446: 113-123.
11. Cao W, Fan R, Wang L, Cheng S, Li H, Jiang J et al. Expression and regulatory function of miRNA-34a in targeting survivin in gastric cancer cells. Tumor Boil 2013; 34: 963-971.
12. Shen Z, Zhan G, Ye D, Ren Y, Cheng L, Wu Z et al. MicroRNA-34a affects the occurrence of laryngeal squamous cell carcinoma by targeting the antiapoptotic gene survivin. Med Oncol 2012; 29: 2473-2480.
13. Saini S, Majid S, Yamamura S, Tabatabai L, Suh SO, Shahryari V et al. Regulatory role of mir-203 in prostate cancer progression and metastasis. Clin Cancer Res 2011; 17: 5287-5298.
14. Xu D, Wang Q, An Y, Xu L. MiR-203 regulates the proliferation, apoptosis and cell cycle progression of pancreatic cancer cells by targeting Survivin. Mol Med Rep 2013; 8: 379-384.
15. Wei W, Wanjun L, Hui S, Dongyue C, Xinjun Y, Jisheng Z. miR-203 inhibits proliferation of HCC cells by targeting survivin. Cell Biochem Funct 2013; 31: 82-85.
16. Donahue JM, Chang ET, Xiao L, Wang PY, Rao JN, Turner DJ et al. The RNA-binding protein HuR stabilizes survivin mRNA in human oesophageal epithelial cells. Biochem J 2011; 437: 89-96.
17. Matsushima K, Isomoto H, Kohno S, Nakao K. MicroRNAs and esophageal squamous cell carcinoma. Digestion 2010; 82: 138-144.
18. Huang SD, Yuan Y, Zhuang CW, Li BL, Gong DJ, Wang SG et al. MicroRNA-98 and microRNA-214 post-transcriptionally regulate enhancer of zeste homolog 2 and inhibit migration and invasion in human esophageal squamous cell carcinoma. Mol Cancer 2012; 11: 51-61.
19. Ciafrè SA, Galardi S. MicroRNAs and RNA-binding proteins: a complex network of interactions and reciprocal regulations in cancer. RNA Biol 2013; 10: 935-942.
20. Cui YH, Xiao L, Rao JN, Zou T, Liu L, Chen Y et al. miR-503 represses CUG-binding protein 1 translation by recruiting CUGBP1 mRNA to processing bodies. Mol Biol Cell 2012; 23: 151-162.
21. Yang H, Kong W, He L, Zhao JJ, O'Donnell JD, Wang J et al. MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res 2008; 68: 425-433.
22. Zhang ZC, Li YY, Wang HY, Fu S, Wang XP, Zeng MS et al. Knockdown of miR-214 promotes apoptosis and inhibits cell proliferation in nasopharyngeal carcinoma. PLoS One 2014; 9: 1-10.
23. Duan Q, Wang X, Gong W, Ni L, Chen C, He X et al. ER stress negatively modulates the expression of the miR-199a/214 cluster to regulates tumor survival and progression in human hepatocellular cancer. PLoS One 2012; 7: 1-10.
24. Wang F, Liu M, Li X, Tang H. MiR-214 reduces cell survival and enhances cisplatin-Induced cytotoxicity via down-regulation of Bcl2l2 in cervical cancer cells. FEBS Lett 2013; 587: 488-495.
25. Xia H, Ooi LL, Hui KM. MiR-214 targets β-catenin pathway to suppress invasion, stemlike traits and recurrence of human hepatocellular carcinoma. PLoS One 2012; 7: 1-13.
26. Talwar S, Balasubramanian S, Sundaramurthy S, House R, Wilusz CJ, Kuppuswamy D et al. Overexpression of RNA-binding protein CELF1 prevents apoptosis and destabilizes pro-apoptotic mRNAs in oral cancer cells. RNA Biol 2013; 10: 277-286.
27. Gareau C, Fournier MJ, Filion C, Coudert L, Martel D, Labelle Y et al. p21(WAF1/CIP1) upregulation through the stress granule-associated protein CUGBP1 confers resistance to bortezomib-mediated apoptosis. PLoS One 2011; 6: 1-14.
28. Richie ME, Silver S, Oshlack A, Holmes M, Diyagama D, Holloway A et al. A comparison of background correction methods for two-colour microarrays. Bioinformatics 2007; 23: 2700-2707.
29. Smyth GK. Limma linear models for microarray data. In: Gentleman R, Carey V, Huber W, Irizarry R, Dudoit S (eds). Bioinformatics and Computational Biology Solutions using R and Bioconductor. Springer: New York, 2005, pp 397-420.
30. Brennan SE, Kuwano Y, Alkharouf N, Blackshear PJ, Gorospe M, Wilson GM. The mRNA-Destabilizing protein tristeraprolin is suppresses in many cancers, altering tumorigenic phenotypes and patient prognosis. Cancer Res 2009; 69: 5168-5176.
31. Orom UA, Lund AH. Isolation of microRNA targets using biotinylated synthetic microRNAs. Methods 2007; 43: 162-165.
32. Choi YE, Pan Y, Park E, Konstantinopoulos P, De S, D'Andrea A et al. MicroRNAs down-regulate homologous recombination in the G1 phase of cycling cells to maintain genomic stability. eLIFE 2014; 3: e02445.
33. Liu L, Rao JN, Zou T, Xiao L, Wang PY, Turner DJ et al. Polyamines regulate c-Myc translation through Chk2-dependent HuR phosphorylation. Mol Biol Cell 2009; 20: 4885-4898.